Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Dupilumab can both heal and cause hair loss.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Infliximab may cause hair loss in Crohn's disease patients.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.